Gazette.govt.nzPursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines which were referred to the Minister of Health under the provisions of section 24(5) of the Act and are set out in the Schedule hereto:
Schedule
| Product: | Escitalopram – Apotex |
| Active Ingredient: | Escitalopram oxalate 6.37mg equivalent to escitalopram 5mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Escitalopram – Apotex |
| Active Ingredient: | Escitalopram oxalate 12.74mg equivalent to escitalopram 10mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Escitalopram – Apotex |
| Active Ingredient: | Escitalopram oxalate 25.47mg equivalent to escitalopram 20mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Ipca-Escitalopram Tablets |
| Active Ingredient: | Escitalopram oxalate 6.37mg equivalent to escitalopram 5mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Ipca-Escitalopram Tablets |
| Active Ingredient: | Escitalopram oxalate 12.74mg equivalent to escitalopram 10mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
| Product: | Ipca-Escitalopram Tablets |
| Active Ingredient: | Escitalopram oxalate 25.47mg equivalent to escitalopram 20mg |
| Dosage Form: | Film coated tablet |
| New Zealand Sponsor: | Ipca Pharma (NZ) Pty Limited |
| Manufacturer: | Ipca Laboratories Limited, Silvassa, India |
Dated this 2nd day of May 2024.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).